Additionally, S100B is associated with the activation of oxidative stress-related pathways, which worsen the neuroinflammatory condition in individuals with DS, heightening their vulnerability to neurodegenerative diseases such as AD51-53. This evidence concerns the gene S100B and Dravet syndrome.